videoSlug

VideoSlug_VideoQuery

slug

VideoPageContentQuery

content

videos

query VideoSlug_VideoQuery(
  $videoSlug: String!
) {
  ...VideoPageContentQuery_1X4EH4
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment LatestVideos_Videos on Query {
  videos(first: 5, upcoming: false, order: {field: liveTime, direction: DESC}) {
    edges {
      node {
        id
        title
        lang
        pageUrl
        liveTime
        isLive
        companies {
          name
          squareLogoUrl
          id
        }
      }
    }
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment VideoPageContentQuery_1X4EH4 on Query {
  content(slug: $videoSlug, type: [VIDEO, WEBCAST]) {
    __typename
    id
    title
    slug
    lang
    htmlBody
    isPremium
    companies {
      viewerIsFollowing
      id
      name
      pageUrl
      defaultInstrument {
        id
        isin
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    createdAt
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    ... on Video {
      imgUrl
      videoEmbedUrl(location: "inderes")
      audioEmbedUrl
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ... on Webcast {
      imgUrl
      videoEmbedUrl(location: "inderes")
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
  }
  ...LatestVideos_Videos
}


type

__typename

title

lang

htmlBody

isPremium

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

first

order

upcoming

edges

Hansa Biopharma

Hansa Biopharma expects to publish its report for Q1 on Thursday, April 20th. On that occasion, HC Andersen Capital will be hosting a digital event on Monday, April 24th at 13.00 where you will be able to meet Head Of Investor Relations Klaus Sindahl who will review highlights from the report and the quarter in general, and take questions.


<section id="vs-about-section" class="about widgets ng-scope">
<div class="container">
<div class="content content-center">
<div class="intro">
<p>Hansa Biopharma expects to publish its report for Q1 on Thursday, April 20th. On that occasion, HC Andersen Capital will be hosting a digital event on Monday, April 24th at 13.00 where you will be able to meet Head Of Investor Relations Klaus Sindahl who will review highlights from the report and the quarter in general, and take questions.<br /><br />At the event, you can expect an update on the commercialization of Idefirix in Europe where Hansa Biopharma continues to announce new reimbursement agreements in individual European countries to support the roll-out of Idefirix &ndash; the latest one in Spain. You can also expect to get a pipeline update regarding the imlifidase technology platform that holds great potential in several other indications than transplantations such as autoimmune deceases, gene therapy, and oncology. Lastly, you will get an update on the current progress of enrollment of patients to the pivotal ConfIdeS clinical trial in the US that will pave the way for the approval and selling of Idefirix into the US transplantation-market. Enrollment to ConfIdeS is expected to be completed in the first half of 2023.<br /><br /><strong>Disclaimer:</strong> HC Andersen Capital receives payment from Hansa Biopharma for a DigitalIR/Corporate Visibility agreement. /Claus Thestrup 10:42 AM 12th of April 2023.</p>
</div>
</div>
</div>
</section>

HC Andersen Capital

Hansa Biopharma - Presentation of Q1 interim report 2023

Ørsted

Vestas Wind Systems

Novo Nordisk

Novonesis

Danske Bank

HCA 2025 forudsigelser - Ramte lidt uden for skiven

Scandinavian Medical Solutions

Per Aarsleff Holding

HCA Morgenbørs 16/12 - Vi ser ind i et røde europæiske futures, dog delvist beskyttet af mindre tech eksponering

Recent videos